The herbal components that make up the medicinal product have secretolytic, antispasmodic, and partially antimicrobial properties.
Essential oils and flavonoids of thyme herb have bronchospasmolytic and secretolytic effects. Saponins from ivy leaves also cause secretolytic effects. In addition, preparations from ivy leaves have an antispasmodic effect on smooth muscles and significantly reduce bronchoconstriction. The antibacterial effect of the drug Bronchipret, due to the thymol component of the essential oil of thyme herb, has also been confirmed.
Active ingredients
Ivy saponins have a rather low absorption rate. The thymol component of thyme essential oil is excreted mainly by the lungs. Flavonoids (e.g. apigenin, luteolin) of thyme herb are broken down by the intestinal flora and are well absorbed into the blood and excreted either unchanged or as metabolites, mainly by the kidneys.
Indication
Treatment of acute bronchitis and inflammatory diseases of the respiratory tract, accompanied by cough with the formation of viscous sputum.
Increased
sensitivity to the components of the drug Bronchipret, as well as to other medicinal plants of the Labiatae or Araliaceae family, to birch pollen, wormwood and celery; children under 2 years of age due to the risk of worsening respiratory symptoms. Bronchipret syrup should not be taken by patients with hereditary fructose intolerance.
Method of administration and doses
The drug Bronchipret should be taken using a measuring cap 3 times a day in the doses indicated in the table, according to age:
| Age | Dosage in ml (3 times a day) | daily dose |
| Children from 2 to 5 years old | 3.2 ml | 9.6 ml |
| Children from 6 to 11 years old | 4.3 ml | 12.9 ml |
| Children from 12 years old and adults | 5.4 ml | 16.2 ml |
It is recommended to drink undiluted Bronchipret syrup with a small amount of liquid (preferably water), for children under 6 years of age, a single dose of syrup should be diluted in 1 tablespoon of water. During storage, turbidity or precipitation may occur - this does not affect the effectiveness of the Bronchipret drug. The syrup should be shaken before use.
The duration of treatment with Bronchipret depends on the course of the disease. Usually the course of treatment is 7 days, if long-term treatment is necessary or if the symptoms of the disease last more than a week, the patient should consult a doctor.
Bronchipret syrup can be taken with or without food and drink. If you have a sensitive stomach, Bronchipret syrup should be taken after a meal.
Overdose
May cause stomach upset, nausea, vomiting, diarrhea, and agitation. In case of overdose, consult a doctor.
Treatment is symptomatic.
Adverse reactions
Gastrointestinal disorders, including cramps, nausea, vomiting, diarrhea, are uncommon. In rare cases, hypersensitivity reactions, including difficulty breathing, skin rashes, couperose, itching, allergic dermatitis, urticaria, swelling of the face, mouth and/or throat, are possible.
At the first signs of any adverse reaction, you should stop using the medicine and consult a doctor.
Application features
If symptoms persist for more than 1 week or worsen with use, if difficulty breathing, fever, purulent or bloody sputum occurs, the patient should consult a doctor.
Due to the ethanol content of 7% (v/v), the drug should be used with caution in patients from risk groups, namely those with liver disease or epilepsy, and the syrup should not be used in children in doses exceeding the recommended ones.
Concomitant use of antitussives such as codeine or dextromethorphan is not recommended. Patients with gastritis or stomach ulcers should not use Bronchipret syrup without consulting a doctor.
Prolonged or recurrent cough in children aged 2 to 4 years requires medical diagnosis before treatment.
Note for diabetics: A single dose of syrup (5.4 ml) for adults contains an average of 0.18 XE (XO).
Use during pregnancy or breastfeeding
Due to insufficient data on the safety of the drug, Bronchipret should not be used during pregnancy and breastfeeding.
Children
Bronchipret should not be used in children under 2 years of age.
Ability to influence reaction speed when driving vehicles or other mechanisms
There is no information on the direct effect of Bronchipret in recommended doses on the ability to drive or use other mechanisms, but patients should be aware that Bronchipret contains ethanol.
Composition
Active ingredients Bronchipret: 10 g (corresponding to 8.92 ml) of syrup contain
1.5 g of liquid thyme herb extract (1: (2 - 2.5)) (Herba Thymi vulgaris) (extractant: ammonium solution 10% / glycerin 85% / ethanol 90% / purified water (1: 20: 70: 109)) 0.15 g of liquid ivy leaf extract (1: 1) (Folium Hederae helicis) (extractant: ethanol 70%);
Bronchipret excipients: ethanol 7% (v/v), liquid maltitol, potassium sorbate, citric acid, hydroxypropyl betadex, purified water.
1 ml of Bronchipret syrup contains 0.07 ml of ethanol (7%).
Interaction with other medicinal products and other types of interactions
Interaction with other drugs has not been observed. Bronchipret can be used as part of complex therapy also in combination with antibacterial drugs.
To protect from light, store in the original packaging at a temperature not exceeding 25 ° C, out of the reach of children.
Shelf life - 3 years.
Do not use Bronchipret after the expiration date stated on the package.
After opening the bottle, Bronchipret can be used for 6 months.
The expiration date determines the use of the drug Bronchipret until the last day of the month.
